HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Both Sildenafil And Tadalafil Found In Spiked Supplements

This article was originally published in The Rose Sheet

Executive Summary

FDA finds products promoted for sexual enhancement and with brands such as "Man of Steel" and "Royal Master" contain one or both of tadalafil or sildenafil, active ingredients in prescription drugs indicated for ED.

You may also be interested in...



Sales Of Drug-Spiked Rhino Supplements Trouble FDA After Importer's Arrest

FDA's consumer warning about "Rhino" brand male enhancement products "due to a recent rise in reported health issues" marks latest detected use of ED ingredients in products fraudulently labeled as supplements and latest example of businesses flouting s regulatory framework that allows sales of most supplements without any pre-market approval process. FDA also uses announcement to recommend consumers ask for a health care provider's advice before "using or considering using any product marketed as a dietary supplement."

Spiked Supplement Holiday Deliveries Stopped By Import Examinations

FDA alerts consumers and health care providers to 13 products found in examinations of international mail shipments to contain sildenafil and one with the banned drug sibutramine.

Ready, Set, Guidance: FDA Releases Final Details Ahead Of ASCA Pilot Launch

A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel